Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of n Dermatological Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of n Dermatological Drugsmarket, defines the market attractiveness level of n Dermatological Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of n Dermatological Drugs industry, describes the types of n Dermatological Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global n Dermatological Drugs market and the development prospects and opportunities of n Dermatological Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global n Dermatological Drugs market in Chapter 13.
By Player:
GlaxoSmithKline
Bayer
Galderma
AbbVie
Merck
Amgen
AstraZeneca
Johnson & Johnson
Pfizer
Novartis
By Type:
By drug type
Prescription-Based Drugs
Over-the-Counter Drugs
By route of administration
Topical Administration
Oral Administration
Parenteral Administration
By dermatological diseases
Acne
Dermatitis
Psoriasis
Skin Cancer
Rosacea
Alopecia
Others
By End-User:
Hospitals
Specialty clinics
Cosmetic centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 n Dermatological Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 n Dermatological Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 n Dermatological Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 n Dermatological Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise n Dermatological Drugs Market Analysis and Outlook to 2022
-
7.1 Global n Dermatological Drugs Consumption (2017-2022)
-
7.2 United States n Dermatological Drugs Consumption (2017-2022)
-
7.3 Europe n Dermatological Drugs Consumption (2017-2022)
-
7.4 China n Dermatological Drugs Consumption (2017-2022)
-
7.5 Japan n Dermatological Drugs Consumption (2017-2022)
-
7.6 India n Dermatological Drugs Consumption (2017-2022)
-
7.7 South Korea n Dermatological Drugs Consumption (2017-2022)
8 Region and Country-wise n Dermatological Drugs Market Analysis and Outlook to 2028
-
8.1 Global n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.2 United States n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.3 Europe n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.4 China n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.5 Japan n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.6 India n Dermatological Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea n Dermatological Drugs Consumption Forecast (2022-2028)
9 Global n Dermatological Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global n Dermatological Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global By drug type Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prescription-Based Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Over-the-Counter Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global By route of administration Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Topical Administration Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Oral Administration Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Parenteral Administration Consumption and Growth Rate (2017-2022)
-
9.1.8 Global By dermatological diseases Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Acne Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Dermatitis Consumption and Growth Rate (2017-2022)
-
9.1.11 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.1.12 Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
9.1.13 Global Rosacea Consumption and Growth Rate (2017-2022)
-
9.1.14 Global Alopecia Consumption and Growth Rate (2017-2022)
-
9.1.15 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global n Dermatological Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Specialty clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cosmetic centers Consumption and Growth Rate (2017-2022)
10 Global n Dermatological Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global n Dermatological Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global By drug type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prescription-Based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Over-the-Counter Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global By route of administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Topical Administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Oral Administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Parenteral Administration Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global By dermatological diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Acne Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Dermatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.11 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.12 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.13 Global Rosacea Consumption Forecast and Growth Rate (2022-2028)
-
10.1.14 Global Alopecia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.15 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global n Dermatological Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Specialty clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Cosmetic centers Consumption Forecast and Growth Rate (2022-2028)
11 Global n Dermatological Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global n Dermatological Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global n Dermatological Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 n Dermatological Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global n Dermatological Drugs Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline n Dermatological Drugs Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer n Dermatological Drugs Product and Service
-
14.3 Galderma
-
14.3.1 Galderma Company Details
-
14.3.2 Galderma n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Galderma n Dermatological Drugs Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie n Dermatological Drugs Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck n Dermatological Drugs Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen n Dermatological Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca n Dermatological Drugs Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson n Dermatological Drugs Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer n Dermatological Drugs Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis n Dermatological Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of n Dermatological Drugs
-
Figure n Dermatological Drugs Picture
-
Table Global n Dermatological Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global n Dermatological Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global n Dermatological Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global n Dermatological Drugs Consumption by Country (2017-2022)
-
Figure United States n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure China n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure India n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea n Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global n Dermatological Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea n Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global By drug type Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription-Based Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Over-the-Counter Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global By route of administration Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Administration Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Administration Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Administration Consumption and Growth Rate (2017-2022)
-
Figure Global By dermatological diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Acne Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatitis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Rosacea Consumption and Growth Rate (2017-2022)
-
Figure Global Alopecia Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Cosmetic centers Consumption and Growth Rate (2017-2022)
-
Figure Global By drug type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prescription-Based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Over-the-Counter Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global By route of administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Administration Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global By dermatological diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acne Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rosacea Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alopecia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cosmetic centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global n Dermatological Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global n Dermatological Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline n Dermatological Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer n Dermatological Drugs Product and Service
-
Table Galderma (Foundation Year, Company Profile and etc.)
-
Table Galderma n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma n Dermatological Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie n Dermatological Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck n Dermatological Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen n Dermatological Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca n Dermatological Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson n Dermatological Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer n Dermatological Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis n Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis n Dermatological Drugs Product and Service
-
